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Cortical blindness secondary to posterior reversible encephalopathy syndrome, 
recovered by successful blood pressure management
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ABSTRACT
We report a case of cortical blindness secondary to posterior leukoencephalopathy 
syndrome, which was successfully treated by blood pressure management. A 
66-year-old white man presented at the emergency room complaining of severe 
frontal headache, disorientation, and progressive blurred vision. The initial physical 
examination disclosed a blood pressure of 200/176 mmHg. One hour later the pa-
tient exhibited mental confusion and bilateral blindness. Computed tomography 
and magnetic resonance imaging were performed, and a systemic workup was 
conducted, resulting in a diagnosis of posterior leukoencephalopathy syndrome. 
This syndrome is a rare manifestation of systemic hypertension that requires proper 
diagnosis and management to avoid irreversible brain damage. Early recognition 
of this condition and prompt control of the patient’s blood pressure are essential 
because they may bring about a reversal of the syndrome, which may otherwise 
result in permanent brain damage.
Keywords: Blindness; Hypertensive encephalopathy; Hypertension; Hypertensive 
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RESUMO 
Relatamos um caso de cegueira cortical secundário à síndrome de leucoencefalopatia 
posterior recuperado pelo controle bem sucedido da pressão arterial. Um homem 
branco de 66 anos de idade compareceu à emergência com queixa de dor de cabeça 
frontal severa, desorientação e embaçamento progressivo da visão. O exame físico 
inicial revelou uma pressão arterial de 200/176 mmHg. Uma hora depois, o paciente 
apresentou confusão mental e cegueira bilateral. Após a tomografia e a ressonância 
nuclear magnética, o tratamento sistêmico foram realizados e o diagnóstico de 
síndrome da leucoencefalopatia posterior foi realizado. A síndrome de leucoencefa­
lopatia posterior é uma manifestação rara de hipertensão sistêmica que requer um 
diagnóstico e gerenciamento adequados para evitar danos cerebrais irreversíveis. O 
reconhecimento precoce desta condição e o controle imediato da pressão arterial são 
essenciais porque podem levar à reversão da síndrome, o que, de outra forma, pode 
resultar em dano cerebral permanente.
Descritores: Cegueira; Encefalopatia hipertensiva; Hipertensão; Encefalopatia hi­
pertensiva; Síndrome da leucoencefalopatia posterior; Humanos; Relatos de casos
INTRODUCTION
Posterior reversible encephalopathy syndrome (PRES) is a rare 
manifestation of systemic hypertension that requires proper diagnosis 
and management to avoid irreversible brain damage. Visual distur-
bances are common, even in absence of funduscopic abnormalities. 
Early recognition of this condition and prompt control of the patient’s 
blood pressure are essential because they can bring about a reversal 
of the syndrome, which may otherwise result in permanent brain 
damage(1).
CASE REPORT 
A 66-year-old white man presented at the emergency room com-
plaining of severe frontal headache, disorientation, and progressive 
bilateral blurred vision. He had a history of poorly controlled systemic 
hypertension since the age of 20 years and had experienced an epi-
sode of intracerebral hemorrhage 20 years earlier, which had left as 
squeal bilateral visual field defects and optic neuropathy in the right 
eye. He was under treatment with amlodipine besylate (10 mg/day) 
and carvedilol (25 mg/day).
On admission, physical examination revealed a blood pressure of 
200/176 mmHg. His visual acuity was classified as “counting fingers” in 
both eyes, but one hour later it deteriorated to “no light perception” 
in both eyes. The eye fundus examination was normal (Figure 1). The 
patient’s pupils were isochoric with a normal light reflex. Neurologic 
examination showed mental confusion and the electroencepha-
lography revealed slow background activity and the loss of alpha 
rhythm in the posterior pole. Blood laboratory tests revealed no 
abnormalities. Electrocardiography and the chest X-ray were normal. 
An immediate computed tomography (CT) scan was negative for in-
tracranial hemorrhage but showed dilation of the right occipital horn 
and moderate signs of cortical and subcortical atrophy. Magnetic 
resonance imaging (MRI) acquired 24 hours after admission revealed 
a cortical hyperintense lesion in the left cerebellar hemisphere and an 
enlarged right ventricle judged to be secondary to a previous infarct 
(Figure 2). In addition, apparent diffusion coefficient maps obtained 
during the PRES revealed increased diffusion in the occipital regions 
indicative of vasogenic edema (Figure 3).
Three hours after the administration of sublingual nifedipine 
(10 mg), the patient’s blood pressure decreased to 110/80 mmHg. 
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Figure 2. Axial FLAIR-weighted (left) and coronal T2-weighted (right) images showing 
a hyperintense lesion in the left cerebellar hemisphere (arrows). Note the enlarged right 
ventricle secondary to a previous infarct.
Figure 1. Eye fundus of a 66-year-old man with posterior 
reversible encephalopathy syndrome. The funduscopic exa-
mination of both eyes was normal.
Figure 3. Apparent diffusion coefficient map for the patient with pos-
terior reversible encephalopathy syndrome. This showed an increased 
signal in the occipital regions indicative of vasogenic edema.
DISCUSSION
PRES is a rare manifestation of hypertension that requires proper 
diagnosis and management to avoid irreversible brain damage(1). 
The syndrome is also known as hypertensive encephalopathy and 
posterior leukoencephalopathy syndrome(2,3).
The most common cause of PRES is an abrupt elevation of blood 
pressure in an otherwise chronically hypertensive patient. This was 
the case for our patient, who suffered from systemic hypertension 
that was poorly controlled and then presented with a sudden increa-
se in blood pressure. PRES may also occur after a moderate elevation 
of systemic blood pressure(3). Other concurrent conditions may 
predispose patients with elevated blood pressure to this syndrome, 
including chronic renal parenchymal disease, acute glomerulone-
phritis, renovascular hypertension, withdrawal from hypertensive 
agents, encephalitis, meningitis, pheochromocytoma, sympathomi-
metic agents, lysergic acid diethylamide), eclampsia and preeclamp-
sia, head trauma, collagen vascular disease, autonomic hyperactivity, 
vasculitis, the ingestion of tyramine-containing foods or tricyclic 
antidepressants in combination with monoamine oxidase inhibitors, 
and immunosuppressive drugs. We had no evidence of any of these 
circumstances being present in our patient. The exact mechanism by 
which PRES occurs is not known with certainty, but recent evidence 
points to vasogenic edema from a loss of autoregulation in cerebral 
blood vessels(4).
Visual disturbances are common in PRES, even in the absence of 
funduscopic abnormalities(5). In our case, the eye fundus examination 
was normal, indicating that the loss of vision must have been caused 
by changes somewhere else in the visual pathway. The presence 
of cortical visual symptoms remains a helpful diagnostic feature 
indicating occipital lobe involvement. Retinal or optic disc ischemia 
and papilledema have been implicated when patients have visual 
complaints(6), but occipital lobe involvement must be considered 
when the fundi appear normal or there are occasional visuospatial 
or speech disturbances(5). Typical visual symptoms range from a 
nonspecific blurriness with normal visual acuity to color-blindness, 
visual field defects, and even complete blindness. Visual hallucina-
tions, the impairment of facial recognition (prosopagnosia), parietal 
Treatment was continued with a salt-free diet, losartan (50 mg/day), 
carvedilol (25 mg/day), and amlodipine besylate (10 mg/day). Two 
days later, the neurologic signs and symptoms vanished and his visual 
acuity recovered to the baseline level. The final diagnosis was PRES 
secondary to systemic hypertension. A CT scan and MRI acquired one 
week and 15 months later did not show any abnormalities other than 
those the patient had previous to this episode. 
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lobe dysfunction with inappropriate behavior, the denial of blindness 
(Anton’s syndrome), and blindness with intact pupillary light reflex 
may simulate drug ingestion or withdrawal, complex migraine, or 
even a psychiatric illness. Isolated cortical blindness, as occurred in 
our patient, and occipital lobe seizures as a manifestation of hyper-
tensive encephalopathy, have also been reported(7).
Typical imaging features of PRES include hypodense regions within 
the posterior white matter regions on unenhanced CT scans and 
areas of hyperintense signal on T2-weighted MRI images. Diffu-
sion-weighted MRI and quantification of the apparent diffusion 
coefficient usually reveal vasogenic edema in the parieto-occipital 
regions of both cerebral hemispheres. The subcortical white mat-
ter is always affected and the cortex is often involved. The edema 
is usually asymmetric, but almost always bilateral(4). Lesions are not 
enhanced after the administration of contrast material. In our case, 
MRI revealed a hyperintense lesion in the left cerebellar hemisphere 
with vasogenic edema in the occipital regions.
Once a patient is diagnosed with PRES, action must be taken 
imme diately to lower the blood pressure, and the administration 
of intravenous antihypertensive agents is sometimes required. In 
our case, we achieved successful blood pressure management with 
oral medication alone. Two days after starting oral antihypertensive 
treatment, the neurologic signs and symptoms disappeared and the 
patient’s visual function recovered. A similar outcome was reported 
in a series of 15 patients with findings indicating posterior leukoen-
cephalopathy, and the condition was therefore termed reversible 
posterior leukoencephalopathy syndrome(8). Because patients with 
PRES may initially present with only subtle symptoms such as blurred 
vision, awareness of this disorder may help to reach a prompt diag-
nosis and instigate proper management to achieve a full recovery 
within a few days(1).
Early recognition of this condition and the prompt control of 
blood pressure are essential because they can reverse the syndrome, 
which may otherwise result in permanent brain damage.
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